Introduction
============

The effectiveness, safety, and stability of using laser-assisted in situ keratomileusis (LASIK) for the correction of refractive errors have been well documented. Early in the development of LASIK, complications related to the use of microkeratomes were reported. These complications included free caps, flap button holes, and instances of suction loss.[@b1-opth-6-1567]--[@b3-opth-6-1567] When compared to manual microkeratomes, femtosecond lasers create flaps with more planar architectures and also improve the precision of flap thickness.[@b4-opth-6-1567],[@b5-opth-6-1567] Several femtosecond lasers, including the IntraLase FS™ series (Abbott Medical Optics, Inc, Irvine, CA), FEMTEC^®^ (20/10 Perfect Vision Optische Geraete GmbH, Heidelberg, Germany), VisuMax^®^ (Carl Zeiss Meditec, Jena, Germany), and Femto LDV (Ziemer Group AG, Port, Switzerland) have been introduced, and the technology has progressed rapidly.

In our clinic, we routinely use both IntraLase FS60 and Femto LDV for lamellar flap creation. The safety of using IntraLase™ femtosecond lasers in terms of the effects on corneal endothelial cells has been documented in the literature, as well as at our clinic.[@b6-opth-6-1567],[@b7-opth-6-1567] To our knowledge, the effects of using Femto LDV on corneal endothelial cells have not been reported elsewhere. In this study, we compared corneal endothelial cell density (ECD), coefficient of variation (CV), and endothelial cell hexagonality changes after LASIK surgery using both IntraLase FS60 and Femto LDV. The level of safety, the relative changes in ECD, residual bed thickness in response to changes in the amount of LASIK correction attempted, as well as each patient's age were also studied.

Materials and methods
=====================

Patients' information
---------------------

In this retrospective comparative analysis, we included patients who visited our clinic for preoperative screening and who underwent LASIK surgery between February and December 2009. Patients were randomly selected, and patients who did not return for follow up visits were excluded from the study. As a result, 254 eyes of 136 patients (male: 94 eyes of 50 patients; female: 160 eyes of 86 patients) who underwent LASIK surgery using Femto LDV (Ziemer Group AG) between April 2009 and December 2009 (LDV group) at the Shinagawa Lasik Center in Tokyo, and 254 eyes of 131 patients (male: 99 eyes of 50 patients; female: 155 eyes of 81 patients) who underwent LASIK using IntraLase FS60 (Abbott Medical Optics) between February 2009 and December 2009 (IntraLase group) at the Shinagawa Lasik Center in Tokyo, Japan were included in the study. All the surgical as well as the pre and postoperative procedures were thoroughly explained to all participating patients, and the patients signed informed consent forms before undergoing the procedure.

The mean age of the patients in the LDV group was 33.6 ± 8.4 years (range: 20 to 59 years), while the mean age of the patients in the IntraLase group was 33.3 ± 7.2 years (range: 18 to 52 years). The mean residual corneal bed thickness for the LDV group was 359 ± 34 μm (range: 296 to 456 μm), and the mean residual corneal bed thickness for the IntraLase group was 367 ± 34 μm (range: 302 to 469 μm). The residual bed thickness was predicted using preoperative pachymetry, attempted flap thickness, and predicted ablation depth. The amount of intended refractive error corrected for both the LDV group and IntraLase group was −5.32 ± 2.24 D (range: −1.50 to −15.88 D) and −4.75 ± 2.05 D (range: −1.13 to −12.75 D), respectively, for the initial correction. None of the eyes had undergone an enhancement or eye surgery prior to the LASIK procedure. Prior to the LASIK surgery, patients used glasses and/or contact lenses to compensate for their refractive error. The period between the cessation of contact lens use and preoperative screening is shown in [Table 1](#t1-opth-6-1567){ref-type="table"}. For the FS60 group, the number and percentage of patients who were wearing soft contact lenses (SCL), hard contact lenses (HCL), both SCL/HCL, and glasses prior to LASIK surgery was 67 (51.1%), 19 (14.5%), 20 (15.3%), and 23 (17.6%), respectively. The number of patients in the LDV group who wore SCL, HCL, both SCL/HCL, and glasses prior to the LASIK procedure was 68 (50.0%), 23 (16.9%), 17 (12.5%), and 28 (20.6%), respectively.

Surgical procedure
------------------

Either Femto LDV or IntraLase FS60 was used to create a lamellar flap. The attempted thickness of the flap created using Femto LDV ranged from 90 to 110 μm (mean: 98 ± 9 μm), and from 85 to 100 μm (mean: 93 ± 6 μm) using IntraLase FS60. Femtosecond laser settings included a pulse energy of 20 to 100 nJ when Femto LDV was used, and both a bed energy of 0.90 μJ and a side cut energy of 0.90 μJ when IntraLase FS60 was used. The repetition rate of the pulse was 1 MHz for Femto LDV and 60 kHz for IntraLase FS60. Given that the spot size (\>1 μm) and energy of IntraLase FS60 is larger than that of Femto LDV (spot size: \<1 μm), and given that the cutting process is driven by mechanical forces disrupting the surrounding tissues, the spot and line separation of IntraLase FS60 is larger than that of Femto LDV. Since smaller spot energy was used by Femto LDV, the disruption occurred locally, resulting in more pulses being required for disruption. After flap creation, excimer laser ablation for refractive correction was performed using ALLEGRETTO WAVE Eye-Q^®^ 400 Hz (WaveLight; Alcon Laboratories, Inc, Ft Worth, TX) for all eyes.

Endothelial cell analysis
-------------------------

In order to evaluate the effects of using femtosecond lasers on corneal endothelial cells both preoperatively and 3 months postoperatively, ECD, CV, and hexagonality were measured with a noncontact specular microscope (Noncon ROBO FA-3509^®^; Konan Medical, Inc, Hyogo, Japan), and the results were compared. The measurement was taken from the central cornea. The preoperative and 3 months postoperative ECD were calculated using the center method. Fifty cells were dotted manually by clicking the center of the cells with a mouse. After doing so, the ECD was estimated, and the cell's morphology was examined for both CV and hexagonality. The postoperative ECD was adjusted by employing the formula demonstrated by Nawa et al,[@b8-opth-6-1567] as the magnification after the LASIK procedure was altered and the amount of endothelial cells were over or underestimated.[@b9-opth-6-1567]

Statistical analysis
--------------------

In order to evaluate the different effects of using two femtosecond lasers on ECD and corneal endothelial morphologies, statistical analysis of the results was performed using either Student's *t*-test, paired Student's *t*-test, or Mann--Whitney's *U*-test where applicable. When comparing the relative differences in ECD, CV, and hexagonal changes at 3 months postoperatively to the preoperative values, Pearson's correlation coefficient was used to determine if there was any relationship with the following parameters: the residual bed thickness, the amount of LASIK correction, and/or the patient's age. Statistical differences with *P* \< 0.05 were considered significant.

Results
=======

Corneal endothelial analysis
----------------------------

The ECD, CV, and hexagonality of the patients' eyes both preoperatively and 3 months postoperatively were measured and compared ([Table 2](#t2-opth-6-1567){ref-type="table"}). No statistically significant differences were found in ECD, CV, and hexagonality between the LDV and IntraLase groups. In addition, no significant difference was observed in pre and postoperative values within the groups (Student's *t*-test, Mann--Whitney's *U*-test, and paired Student's *t*-test, *P* \> 0.05). The mean change in ECD, CV, and hexagonality were −17 ± 247 cells/mm^2^ (a 0.58% decrease), −0.1 ± 9.9 (a 0.30% decrease), and 1.0% ± 13.8% (a 1.75% increase) in the LDV group, respectively. The mean change in ECD, CV, and hexagonality were 22 ± 313 cells/mm^2^ (a 0.76% increase), −0.5 ± 8.8 (a 1.47% decrease), and −0.3% ± 9.6% (a 0.52% decrease) in the IntraLase group, respectively (Student's *t*-test *P* = 0.1273, 0.7522, and 0.3198, respectively).

Factors affecting ECD, CV, and hexagonality over time
-----------------------------------------------------

The correlation coefficient between the change in ECD, CV, and hexagonality in association with the patients' ages, residual bed thickness, and amount of refractive correction were evaluated. In the LDV group, the patient's ECD change and the amount of correction, as well as the patient's age and the change in CV demonstrated a statistically significant correlation (*P* = 0.0138, *r* = −0.154; *P* = 0.0203, *r* = 0.145, respectively). However, with this low correlation coefficient value, there may not be sufficient evidence to prove an actual correlation between the factors. Other factors did not show statistical significance during this comparison.

Discussion
==========

Various studies have been performed evaluating the effect of refractive surgery on the corneal endothelium. Excimer lasers used for photorefractive keratectomy (PRK) have been reported to have no adverse effects on the corneal endothelium.[@b10-opth-6-1567] Similarly, LASIK surgery conducted with a mechanical microkeratome has also been demonstrated to have no effect on the corneal endothelium.[@b11-opth-6-1567],[@b12-opth-6-1567] Since obtaining Food and Drug Administration approval in 2001, a vast number of surgeries have been completed worldwide (including in Japan) using the IntraLase™ femtosecond laser. Reported benefits include more predictable flap thicknesses and planarity, and fewer intraoperative flap complications.[@b13-opth-6-1567]--[@b15-opth-6-1567] In our clinic, various versions of the IntraLase™ femtosecond lasers including FS, FS30, and FS60 have been used. Previously, we reported that the use of IntraLase FS60 for LASIK surgery did not result in damage to the corneal endothelium.[@b7-opth-6-1567]

By comparing the ECD changes of post photorefractive keratotomy and post thin-flap LASIK surgery using the IntraLase FS60, Smith et al[@b15-opth-6-1567] reported that there were no statistically significant changes at 3 months after the PRK or the LASIK procedure when compared to the preoperative value. Furthermore, statistical significance was not observed between the two groups when comparing the ECD changes preoperatively and 3 months after the PRK or the LASIK surgery.[@b15-opth-6-1567] In addition, Sonigo et al[@b16-opth-6-1567] reported that when post-LASIK (femtosecond laser or microkeratome) confocal microscopy images of the endothelial cells were compared, no significant changes were seen in the endothelial morphology over a 12-month observation period.

Currently, a number of femtosecond laser models are available. The technical differences between Femto LDV and IntraLase FS60 are worth describing. The spot size for Femto LDV is less than 1 μm, while the spot size for IntraLase FS60 is more than 1 μm.[@b17-opth-6-1567] The pulse energy for Femto LDV is about 20 to 100 nJ, while the IntraLase FS60 is 1 μJ. The repetition rate for Femto LDV is higher (1 MHz) than the 60 kHz noted for IntraLase.[@b17-opth-6-1567] In addition, the cutting process of the IntraLase FS60 is driven by mechanical forces, which disrupt an area of tissue that is larger than the spot size. The cutting process of the Femto LDV differs given that the disruption is confined to the focal spot size of the laser pulse, which results in more pulses being required in order to cut the same area.[@b17-opth-6-1567] With the IntraLase FS60, the energy per pulse is higher than the individual pulse energy of the Femto LDV; however, the total energy used for flap creation was higher when Femto LDV was used since the total number of pulses required was higher.

It has been demonstrated that keratocyte apoptosis and postoperative inflammation after LASIK procedures occur in association with use of high pulse energy femtosecond lasers.[@b18-opth-6-1567],[@b19-opth-6-1567] Moreover, it has been reported that the difference in the cutting processes could affect flap creation, especially if the patients had corneal opacity.[@b20-opth-6-1567] The mechanical forces produced by IntraLase FS60 could break through Bowman's layer when it disrupts sections with corneal opacity, while Femto LDV is able to disrupt opacity without a problem.[@b20-opth-6-1567] In our study, we observed that ECD, CV, and endothelial cell hexagonality were stable at 3 months after LASIK surgery in both the LDV and the IntraLase groups.

At 3 months post LASIK surgery, the mean ECD as measured from the center of the cornea increased by 0.76% in the IntraLase group, and the mean hexagonal cell percentage increased by 1.75% in the LDV group. These increases were not statistically significant when comparing the values preoperatively and 3 months postoperatively. Prior to LASIK surgery, a majority of the patients were wearing soft and/or hard contact lenses, but stopped their use after the LASIK procedure. Sheng and Bullimore[@b21-opth-6-1567] demonstrated that wearing contact lenses was the most significant factor affecting morphological and ECD count change of the endothelium. It has been reported that stopping the use of contact lenses may be related to an increase in central ECD as peripheral cells reposition to the central area.[@b22-opth-6-1567],[@b23-opth-6-1567] Furthermore, positive morphological changes such as a decrease in CV and an increase in hexagonal cell percentage have also been reported to have a relation to the termination of contact lens use.[@b23-opth-6-1567] These reports may explain why we observed an increase in the ECD and hexagonal cell percentages in our study.

On the other hand, Amoozadeh et al[@b24-opth-6-1567] suggested that the increase in ECD can be attributed to sampling errors before and after surgery since endothelial cells did not divide. Additionally, Trocmé et al[@b25-opth-6-1567] hypothesized that the rearrangement of cells may have masked the true damage of the endothelial cells caused by refractive surgery, and suggested longer term observation in future studies. Nonetheless, we did not observe statistically significant differences between ECD, CV, and hexagonal cell percentage in either the IntraLase or the LDV groups either preoperatively or 3 months postoperatively.

Patel and Bourne[@b26-opth-6-1567] reported that in 9 years of observation, they did not see any significant relationships between ECD reduction and either the amount of refractive correction nor the residual bed thickness after LASIK surgery. They did not mention noting any relationships between CV and hexagonal cell percentage with other factors such as the amount of refractive correction, residual bed thickness, or patient age. In our study, there were no significant correlations between ECD, CV, and hexagonal cell percentage with the amount of refractive correction, residual bed thickness, or patient age in either the IntraLase or the LDV groups at 3 months after LASIK surgery. The limitation to our study is the short follow-up time; yet, our results were consistent with prior reports by Patel and Bourne[@b26-opth-6-1567] describing the lack of any correlation between ECD reduction and the amount of refractive correction or residual bed thickness after LASIK surgery.

In conclusion, the use of either Femto LDV or IntraLase FS60 femtosecond lasers for lamellar flap creation did not appear to have an adverse effect on ECD and/or endothelial morphology. Longer follow up is needed in order to confirm the long-term effect of femtosecond laser use on the corneal endothelium.
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###### 

Period between cessation of contact lens use and preoperative screening

  Length      FS60 group   LDV group                                                                                
  ----------- ------------ ----------- ---------------------------------------------- ---- ---- ---- ---- ---- ---- ----
  7 days      31           25          0                                              6    0    32   29   0    3    0
  14 days     38           20          11                                             7    0    44   28   10   6    0
  21 days     10           6           3                                              0    1    13   3    8    2    0
  30 days     10           6           3                                              1    0    4    0    1    3    0
  60 days     1            1           0                                              0    0    1    1    0    0    0
  90 days     5            2           1[a](#tfn2-opth-6-1567){ref-type="table-fn"}   2    0    3    2    1    0    0
  120 days    1            0           0                                              1    0    2    1    1    0    0
  150 days    1            0           0                                              1    0    1    0    0    1    0
  180 days    3            1           1                                              1    0    3    2    1    0    0
  1 year      1            1           0                                              0    0    1    1    0    0    0
  2 years     3            3           0                                              0    0    2    1    1    0    0
  3 years     2            1           0                                              1    0    --   --   --   --   --
  3.5 years   --           --          --                                             --   --   1    0    0    1    0
  5 years     --           --          --                                             --   --   1    0    0    1    0
  8 years     1            1           0                                              0    0    --   --   --   --   --

**Note:**

Orthokeratology contact lens user.

**Abbreviations:** SCL, soft contact lenses; HCL, hard contact lenses.

###### 

Endothelial cell density and morphology preoperatively and 3 months postoperatively taken from the center of the cornea

                               Pre-op (Mean ± SD)   *P*-value                                           3 months (Mean ± SD)   *P*-value                                           Significance between pre and 3 months post-op (*P*-value)
  ---------------------------- -------------------- --------------------------------------------------- ---------------------- --------------------------------------------------- -----------------------------------------------------------
  ECD (cells/mm^2^)                                                                                                                                                                
   IntraLase group (n = 254)   2913 ± 348           0.8529[a](#tfn5-opth-6-1567){ref-type="table-fn"}   2935 ± 354             0.2688[a](#tfn5-opth-6-1567){ref-type="table-fn"}   0.4868[b](#tfn6-opth-6-1567){ref-type="table-fn"}
   LDV group (n = 254)         2919 ± 328                                                               2902 ± 308                                                                 0.2871[b](#tfn6-opth-6-1567){ref-type="table-fn"}
  CV                                                                                                                                                                               
   IntraLase group (n = 254)   34 ± 7               0.3816[a](#tfn5-opth-6-1567){ref-type="table-fn"}   33 ± 6                 0.3844[c](#tfn7-opth-6-1567){ref-type="table-fn"}   0.3855[b](#tfn6-opth-6-1567){ref-type="table-fn"}
   LDV group (n = 254)         33 ± 6                                                                   33 ± 8                                                                     0.9192[b](#tfn6-opth-6-1567){ref-type="table-fn"}
  Hexagonality (%)                                                                                                                                                                 
   IntraLase group (n = 254)   58 ± 11              0.4978[a](#tfn5-opth-6-1567){ref-type="table-fn"}   58 ± 11                0.5675[a](#tfn5-opth-6-1567){ref-type="table-fn"}   0.8934[b](#tfn6-opth-6-1567){ref-type="table-fn"}
   LDV group (n = 254)         57 ± 11                                                                  58 ± 11                                                                    0.2637[b](#tfn6-opth-6-1567){ref-type="table-fn"}

**Notes:**

Student's *t*-test;

paired Student's *t*-test;

Mann--Whitney's *U*-test.

**Abbreviations:** ECD, endothelial cell density; CV, coefficient of variation.
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